Literature DB >> 1316534

Geographic/ethnic differences in human herpesvirus-6 antibody patterns.

P H Levine1, J Neequaye, M Yadav, R Connelly.   

Abstract

Serum samples from healthy adults in four geographic/ethnic groups (Ghanaian Blacks, Malaysian Chinese, Malaysian Indians and United States Caucasians) were tested under code for antibodies to human herpesvirus-6 (HHV-6). The prevalence and titer of HHV-6 antibody in the healthy Ghanaians were significantly higher than in the Malaysian Chinese; United States Caucasians and Malaysian Indians had intermediate prevalence and titer of antibodies. Thus far, no specific differences in HHV-6-associated diseases have been noted between geographic/ethnic groups with these marked variations in antibody patterns.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316534     DOI: 10.1111/j.1348-0421.1992.tb01654.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Authors:  G Valente; P Secchiero; P Lusso; M C Abete; C Jemma; G Reato; S Kerim; R C Gallo; G Palestro
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults.

Authors:  S W Aberle; C W Mandl; C Kunz; T Popow-Kraupp
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Low-incidence latent infection with variant B or roseola type human herpesvirus 6 in leukocytes of healthy adults.

Authors:  J Rajcáni; R Yanagihara; M S Godec; J W Nagle; M Kudelova; D M Asher
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 5.  An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Authors:  Michael J Wells; Steven Jacobson; Paul H Levine
Journal:  Infect Agent Cancer       Date:  2019-11-05       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.